Databases and in silico tools for vaccine design

Methods in Molecular Biology

Volumn 993, Issue , 2013, Pages 115-127

  He, Yongqun ^a   Xiang, Zuoshuang ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Immune epitope; Immunoinformatics; Reverse vaccinology; Vaccine; Vaccine adjuvant; Vaccine database; Vaccine design; Vaxign; VIOLIN vaccine database and analysis system

Indexed keywords

ANTIGEN; EPITOPE; INFLUENZA VACCINE; LIPOPOLYSACCHARIDE; LIVE VACCINE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NEISSERIA MENINGITIDIS VACCINE; OUTER MEMBRANE PROTEIN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; VACCINE; VIRULENCE FACTOR;

ALGORITHM; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; COMPUTER MODEL; COMPUTER PROGRAM; CYTOTOXIC T LYMPHOCYTE; DATA BASE; DRUG DESIGN; DRUG INDUSTRY; DRUG INFORMATION; DRUG RESEARCH; FOOD AND DRUG ADMINISTRATION; GENE MUTATION; HOST PATHOGEN INTERACTION; INTERNET; MALE; MEDICAL ONTOLOGY; NONHUMAN; ONLINE SYSTEM; PREDICTION; PRIORITY JOURNAL; T LYMPHOCYTE; ANIMAL; BIOLOGY; DRUG DATABASE; HUMAN; IMMUNOLOGY; METHODOLOGY; REVIEW;

ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, PHARMACEUTICAL; DRUG DESIGN; HUMANS; VACCINES;

EID: 84884261709     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-342-8_8     Document Type: Article

References (46)

1. De Groot AS, Sbai H, Aubin CS et al (2002) Immuno-informatics: mining genomes for vaccine components. Immunol Cell Biol 80: 255-269
2. Rappuoli R (2000) Reverse vaccinology. Curr Opin Microbiol 3:445-450
3. He Y, Rappuoli R, De Groot AS, Chen RT (2010) Emerging vaccine informatics. J Biomed Biotechnol 2010:218590
4. Xiang Z, Todd T, Ku KP et al (2008) VIOLIN: vaccine investigation and online information network. Nucleic Acids Res 36:D923-D928
5. He Y, Xiang Z, Mobley HL (2010) Vaxign: the first web-based vaccine design program for reverse vaccinology and applications for vaccine development. J Biomed Biotechnol 2010:297505
6. Bhattacharjee AK, Izadjoo MJ, Zollinger WD et al (2006) Comparison of protective ef ficacy of subcutaneous versus intranasal immunization of mice with a Brucella melitensis lipopolysaccharide subunit vaccine. Infect Immun 74:5820-5825
7. Ansari HR, Flower DR, Raghava GP (2010) AntigenDB: an immunoinformatics database of pathogen antigens. Nucleic Acids Res 38: D847-D853
8. Yang B, Sayers S, Xiang Z, He Y (2011) Protegen: a web-based protective antigen database and analysis system. Nucleic Acids Res 39:D1073-D1078 (database issue)
9. Peters B, Sidney J, Bourne P et al (2005) The immune epitope database and analysis resource: from vision to blueprint. PLoS Biol 3:e91
10. Wang P, Sidney J, Dow C et al (2008) A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 4:e1000048
11. Unanue ER (1992) Cellular studies on antigen presentation by class II MHC molecules. Curr Opin Immunol 4:63-69
12. Brown JH, Jardetzky TS, Gorga JC et al (1993) Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 364:33-39
13. Chicz RM, Urban RG, Gorga JC et al (1993) Speci ficity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 178:27-47
14. Ahlers JD, Belyakov IM, Thomas EK, Berzofsky JA (2001) High-af finity T helper epitope induces complementary helper and APC polarization, increased CTL, and protection against viral infection. J Clin Invest 108:1677-1685
15. Plotnicky H, Cyblat-Chanal D, Aubry JP et al (2003) The immunodominant in fluenza matrix T cell epitope recognized in human induces in fluenza protection in HLA-A2/K(b) transgenic mice. Virology 309:320-329
16. Bulik S, Peters B, Ebeling C, Holzhutter H (2004) Cytosolic processing of proteasomal cleavage products can enhance the presentation ef ficiency of MHC-1 epitopes. Genome Inform 15:24-34
17. Peters B, Bulik S, Tampe R et al (2003) Identifying MHC class I epitopes by predicting the TAP transport ef ficiency of epitope precursors. J Immunol 171:1741-1749
18. Nielsen M, Lundegaard C, Lund O, Kesmir C (2005) The role of the proteasome in generating cytotoxic T-cell epitopes: insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57:33-41
19. Stranzl T, Larsen MV, Lundegaard C, Nielsen M (2010) NetCTLpan: pan-speci fic MHC class I pathway epitope predictions. Immunogenetics 62:357-368
20. Rammensee H, Bachmann J, Emmerich NP et al (1999) SYFPEITHI: database for MHC ligands and peptide motifs. Immunogenetics 50:213-219
21. Parker KC, Bednarek MA, Coligan JE (1994) Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. J Immunol 152:163-175
22. De Groot AS, Martin W (2009) Reducing risk, improving outcomes: bioengineering less immunogenic protein therapeutics. Clin Immunol 131:189-201
23. Zhang Q, Wang P, Kim Y et al (2008) Immune epitope database analysis resource (IEDB-AR). Nucleic Acids Res 36:W513-W518
24. Lin HH, Zhang GL, Tongchusak S et al (2008) Evaluation of MHC-II peptide binding prediction servers: applications for vaccine research. BMC Bioinformatics 9(Suppl 12):S22
25. Gowthaman U, Agrewala JN (2008) In silico tools for predicting peptides binding to HLAclass II molecules: more confusion than conclusion. J Proteome Res 7:154-163
26. Enshell-Seijffers D, Denisov D, Groisman B et al (2003) The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J Mol Biol 334:87-101
27. Schreiber A, Humbert M, Benz A, Dietrich U (2005) 3D-Epitope-Explorer (3DEX): localization of conformational epitopes within three-dimensional structures of proteins. J Comput Chem 26:879-887
28. Kulkarni-Kale U, Bhosle S, Kolaskar AS (2005) CEP: a conformational epitope prediction server. Nucleic Acids Res 33:W168-W171
29. Sweredoski MJ, Baldi P (2008) PEPITO: improved discontinuous B-cell epitope prediction using multiple distance thresholds and half sphere exposure. Bioinformatics 24:1459-1460
30. Blythe MJ, Flower DR (2005) Benchmarking B cell epitope prediction: underperformance of existing methods. Protein Sci 14:246-248
31. Reimer U (2009) Prediction of linear B-cell epitopes. Methods Mol Biol 524:335-344
32. Rajnavolgyi E, Nagy N, Thuresson B et al (2000) A repetitive sequence of Epstein-Barr virus nuclear antigen 6 comprises overlapping T cell epitopes which induce HLA-DRrestricted CD4(+) T lymphocytes. Int Immunol 12:281-293
33. Graham CM, Barnett BC, Hartlmayr I et al (1989) The structural requirements for class II (I-Ad)-restricted T cell recognition of in fluenza hemagglutinin: B cell epitopes de fine T cell epitopes. Eur J Immunol 19:523-528
34. Fleischmann RD, Adams MD, White O et al (1995) Whole-genome random sequencing and assembly of Haemophilus in fluenzae Rd. Science 269:496-512
35. Pizza M, Scarlato V, Masignani V et al (2000) Identi fication of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287:1816-1820
36. Sachdeva G, Kumar K, Jain P, Ramachandran S (2005) SPAAN: a software program for prediction of adhesins and adhesin-like proteins using neural networks. Bioinformatics 21: 483-491
37. He Y, Xiang Z (2010) Bioinformatics analysis of Brucella vaccines and vaccine targets using VIOLIN. Immunome Res 6(Suppl 1):S5
38. Xiang Z, He Y (2009) Vaxign: a web-based vaccine target design program for reverse vaccinology. Procedia Vaccinol 1(1):23-29
39. Xiang Z, Courtot M, Brinkman RR et al (2010) OntoFox: web-based support for ontology reuse. BMC Res Notes 3:175
40. He Y, Cowell L, Diehl AD et al. (2009) VO: Vaccine ontology. The 1st international conference on biomedical ontology (ICBO 2009). 24-26 July 2009, Buffalo, NY. Nature Precedings. http://precedings.nature.com/documents/3553/ version/1 . doi: 10.1038/npre.2009.3553.1 . Accessed 23 Apr 2012.
41. Xiang Z, He Y (2009) Improvement of PubMed literature searching using biomedical ontology. The 1st international conference on biomedical ontology (ICBO 2009). 24-26 July 2009, Buffalo, NY. Nature Precedings . http://precedings.nature.com/documents/3491/version/1 . doi: 10.1038/npre.2009.3491.1 . Accessed 23 Apr 2012
42. Hur J, Xiang Z, Feldman EL, He Y (2011) Ontology-based Brucella vaccine literature indexing and systematic analysis of genevaccine association network. BMC Immunol 12:49
43. Özgür A, Xiang Z, Radev DR, He Y (2011) Mining of vaccine-associated IFN-© gene interaction networks using the vaccine ontology. J Biomed Semantics 2(suppl 2):S8. doi: 10.1186/2041-1480-2-S2-S8
44. Banai M, He Y (2012) Systems biology and bioinformatics help decipher Brucella antigens involved in clinical manifestation of the disease. Front Cell Infect Microbiol 2:34. doi: 10.3389/fcimb.2012.00034
45. Serruto D, Rappuoli R (2006) Post-genomic vaccine development. FEBS Lett 580: 2985-2992
46. Mora M, Donati C, Medini D et al (2006) Microbial genomes and vaccine design: re finements to the classical reverse vaccinology approach. Curr Opin Microbiol 9: 532-536